Dr. Reddy’s Laboratories, Hyderabad-based pharmaceutical company, has reportedly received an approval from the Central Drug Standard Control Organisation (CDSCO) to export drugs for the European Union market. In an order dated August 5, CDSCO gave its nod, which will allow Dr Reddy’s to export 15 active pharmaceutical ingredients (APIs) to the European Union.
These drugs are used to treat hypertension, pneumonia, bacterial infection, cardiovascular diseases and migraine, among others. The order will enable the company to import these substances for a period of three years, ending June 2019.
Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1873.20 |
| Dr. Reddys Lab | 1279.85 |
| Cipla | 1305.95 |
| Zydus Lifesciences | 958.00 |
| Lupin | 2251.75 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: